My podcast guest Stephanie Buxhoeveden was diagnosed with MS when she was 25 years old, working as a neurosurgical ICU nurse. Today, Stephanie is a board-certified Multiple Sclerosis Nurse, she is a Nurse Practitioner and she is the Co-Director of the MS Comprehensive Care Center where she has also been a patient.     Stephanie will share some of her experiences and observations from the dual perspective of someone who is a medical specialist who treats patients with MS, and also someone who lives with MS.   We're also talking about the results of the very first clinical trial to demonstrate a slowing in the progression of disability in secondary progressive MS. We'll tell you about a new Canadian study that shows a clear connection between depression and physical disability in MS. And we'll talk about the kind of information that California's new prescription drug price transparency bill is revealing. ____________

 :18     MS Awareness -- It's A 12-Month Campaign

3:01    New Drug Slows Disability Progression in Secondary Progressive MS

4:09    Study Shows Depression Impacts MS Physical Disability

6:42    Drug Price Transparency Law in California Begins to Reveal Real Information

8:49    Interview with Stephanie Buxhoeveden

___________

LINKSIf your podcast app doesn’t show these links, you’ll find them in the show notes at www.RealTalkMS.com

Articles & Videos by Stephanie Buxhoeveden

GPS For Your MS: Initiating Your Wellness Journey

Emergency Preparedness

Facing the Emotional Symptoms of MS Together

TedX Talk: Thriving In The Face of Adversity

MS Path 2 Care

___________

For more RealTalk MS, follow us on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 26 Guests: Stephanie Buxhoeveden, MSCN, FN-BC, MS Activist Hosted By: Jon Strum

Tags: MS, multiple sclerosis, Stephanie Buxhoeveden, Siponimod, MS and depression, MS prescription drug prices, prescription drug price transparency, MS podcast, RealTalk MS